dabigatran has been researched along with Blood Loss, Postoperative in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (1.82) | 29.6817 |
| 2010's | 49 (89.09) | 24.3611 |
| 2020's | 5 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Gromov, K; Jensen, TB; Jimenez-Solem, E; Olesen, JB; Overgaard, S; Petersen, J; Schelde, AB | 1 |
| Elder, M; Hung, YC; Morris, A | 1 |
| Löser, C; Nast, A; Zeymer, U | 1 |
| Barequet, IS; Bourla, N; Moisseiev, J; Salomon, O; Tamarin, I; Zehavi-Dorin, T | 1 |
| Doyama, H; Fujishiro, M; Fujita, T; Hasatani, K; Hatta, W; Hiasa, Y; Hikichi, T; Igarashi, K; Iguchi, M; Inoue, T; Kawaguchi, K; Kitamura, K; Kuribayashi, S; Mikami, T; Morita, Y; Nishida, T; Nishikawa, J; Oda, I; Sumiyama, K; Sumiyoshi, T; Tomida, H; Tsuji, Y; Uraoka, T; Yada, T; Yamamoto, K; Yanagitani, A; Yoshio, T | 1 |
| Goya, M; Hirao, K; Kawabata, M; Maeda, S; Sasano, T; Takahashi, Y; Yagishita, A | 1 |
| Hocker, TLH; Neill, BC; Singh, AH; Siscos, SM | 1 |
| Dong, YX; Gao, LJ; Li, WW; Ma, CM; Wang, N; Xia, YL; Xiao, XJ; Yang, MH; Yin, XM; Yu, XH; Zhang, RF | 1 |
| Nathwani, S; Wanis, C | 1 |
| Bellmann, B; Landmesser, U; Lenz, K; Lin, T; Lsharaf, AK; Nagel, P; Rillig, A; Roser, M; Tscholl, V | 1 |
| Bayer, N; Geidel, S; Hassan, K; Oberhoffer, M; Schlingloff, F; Schmoeckel, M; Wohlmuth, P | 1 |
| Calabria, S; Dondi, L; Forcesi, E; Maggioni, AP; Martini, N; Pedrini, A | 1 |
| Alviz, I; Avendano, R; Cerna, L; Cerrud-Rodriguez, RC; Di Biase, L; Diaz, JC; Grupposo, V; Kirchhof, P; Kumar, S; Michaud, GF; Natale, A; Romero, J; Taveras, J | 1 |
| Hirao, K; Kurabayashi, M; Nakamura, R; Nishimura, T; Okishige, K; Sasano, T; Shigeta, T; Yamauchi, Y | 1 |
| Alikhan, R; Baglin, T; Benson, G; Green, L; Keeling, D; Marshall, S; Patel, R; Pavord, S; Rayment, R; Rose, P; Tait, C | 1 |
| Castillo, J; de Andrés, J; Ferrandis, R; Gomar, C; Gómez-Luque, A; Hidalgo, F; Llau, JV; Torres, LM | 1 |
| Davis, C; Lee, M; Robertson, C; Shivakumar, S | 1 |
| Eriksson, BI; Quinlan, DJ | 1 |
| Cohen, AA; Rider, T | 1 |
| Kornej, J; Lip, GY; Potpara, T | 1 |
| Fries, D; Giurea, A; Gütl, M; Halbmayer, WM; Kozek-Langenecker, S; Pachucki, A; Roithinger, F; Steinlechner, B; Thaler, H; Weltermann, A | 1 |
| Dütsch, M; Klauser, W | 1 |
| Best, AJ; Bloch, BV; Patel, V | 1 |
| Gálity, H; Gombár, C; Horvath, G; Sisák, K; Tóth, K | 1 |
| John, A; Michel, MS | 1 |
| McCormick, NJ; Meechan, JG; Moore, UJ; Norouzi, M | 1 |
| Bollmann, A; Breithardt, OA; Darma, A; Dinov, B; Doering, M; Hindricks, G; Kosiuk, J; Koutalas, E; Nedios, S; Richter, S; Rolf, S; Sommer, P | 1 |
| Doering, M; Egidy, C; Gehrke, T; Kendoff, D; Krettek, C; Mommsen, P; R O Hrs, E | 1 |
| Ashikhmina, E; Connors, JM; Davidson, M; Jahanyar, J; Mizuguchi, KA; Tomasello, N | 1 |
| Brueckmann, M; Connolly, SJ; Douketis, JD; Eikelboom, JW; Ezekowitz, MD; Fraessdorf, M; Healey, JS; Noack, H; Oldgren, J; Reilly, P; Spyropoulos, AC; Wallentin, L | 1 |
| Chatelain, B; Dincq, AS; Dogné, JM; Douxfils, J; Gourdin, M; Hjemdahl, P; Lessire, S; Mullier, F; Pohanka, A; Rönquist-Nii, Y | 1 |
| Crighton, A; Gibson, J; Scott, A | 1 |
| Warner, CG | 1 |
| Bahl, R; Mohamedbhai, H; Puttick, T | 1 |
| Cattaneo, M; Lussana, F; Squizzato, A | 1 |
| Frische, C; Gawaz, M; Gramlich, M; Schreieck, J; Seizer, P | 1 |
| Bianchi, P; Biondi, A; Crapelli, GB; de Vincentiis, C; Isgrò, G; Ranucci, M | 1 |
| Hansen, PS; Sanchez, R; Walfridsson, H | 1 |
| Munson, CF; Reid, AJ | 1 |
| Pasechnik, IN | 1 |
| Sié, P | 1 |
| Gislason, GH; Lee, CJ; Lindhardt, TB; Olesen, JB; Pallisgaard, JL; Sindet-Pedersen, C; Staerk, L; Torp-Pedersen, C | 1 |
| Casañas-Gil, E; Hernández-Vallejo, G; López-Pintor, RM; Muñoz-Corcuera, M; Ramírez-Martínez-Acitores, L | 1 |
| Butala, NM; Kartoun, U; Kennedy, KF; Mahmood, S; Secemsky, EA; Shaw, SY; Wasfy, JH; Yeh, RW | 1 |
| Gerstrøm, G; Nybo, M; Rosenberg, L | 1 |
| Bocksrucker, C; Drwiła, R; Dulíček, P; Hauer, T; Mutzenbach, J; Schlimp, CJ; Špinler, D; Vosko, MR; Wolf, T; Zugwitz, D | 1 |
| Fujisaki, J; Hirasawa, T; Horiuchi, Y; Igarashi, M; Ishiyama, A; Iwasaki, R; Michitaka, K; Mita, E; Ninomiya, T; Omae, M; Tomida, H; Tsuchida, T; Yamada, T; Yamamoto, Y; Yoshio, T | 1 |
| Carrier, M; de Wit, C; Le Gal, G; Shaw, J | 1 |
| Connolly, SJ; Eikelboom, JW; Lamy, A; Margetts, P; Ricci, C; Warkentin, TE | 1 |
| Caprini, JA; Clemens, A; Eriksson, BI; Friedman, RJ; Kurth, A; Noack, H | 1 |
| Brodmann, M; Domanovits, H; Eber, B; Gottsauner-Wolf, M; Halbmayer, WM; Hiesmayr, JM; Kyrle, PA; Längle, F; Roithinger, FX; Watzke, H; Weltermann, A; Windhager, R; Wolf, C; Zweiker, R | 1 |
| Firriolo, FJ; Hupp, WS | 1 |
| Dumenil, AS; Galbois, A; Lillo-Le Louët, A; Offenstadt, G; Samama, MM; Soufir, L; Wolf, M | 1 |
| Bauersachs, R; Bode, C; Debus, ES; Gawaz, M; Gerlach, H; Haas, S; Hach-Wunderle, V; Lindhoff-Last, E; Riess, H; Schellong, S; Schinzel, H; Spannagl, M | 1 |
| Ma, Q | 1 |
14 review(s) available for dabigatran and Blood Loss, Postoperative
| Article | Year |
|---|---|
[Dermatosurgery in the age of novel oral anticoagulants/direct oral anticoagulants].
Topics: Administration, Oral; Anticoagulants; Dabigatran; Dermatologic Surgical Procedures; Humans; Postoperative Hemorrhage; Practice Guidelines as Topic; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban | 2019 |
Novel oral anticoagulants and exodontia: the evidence.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Oral Surgical Procedures; Postoperative Hemorrhage; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban | 2017 |
Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Cerebral Infarction; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Hemorrhage; Humans; Postoperative Complications; Postoperative Hemorrhage; Risk Factors; Rivaroxaban; Severity of Illness Index; Thromboembolism; Warfarin | 2018 |
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Disease Management; Drug Overdose; Emergency Service, Hospital; Hemorrhage; Humans; Postoperative Hemorrhage | 2014 |
[Recommendations on use of direct oral anticoagulants in the perioperative period].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Dabigatran; Humans; Morpholines; Perioperative Care; Postoperative Hemorrhage; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Withholding Treatment | 2012 |
Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
Topics: Administration, Oral; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; International Normalized Ratio; Postoperative Hemorrhage; Pyridines; Surgery, Oral; Tooth Extraction; Warfarin | 2013 |
Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Heparin, Low-Molecular-Weight; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin | 2013 |
NOACs for thromboprophylaxis in medical patients.
Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Enoxaparin; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Warfarin | 2013 |
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Administration Schedule; Fibrinolytic Agents; Forecasting; Humans; Morpholines; Percutaneous Coronary Intervention; Postoperative Care; Postoperative Hemorrhage; Premedication; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin | 2013 |
Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Blood Coagulation Tests; Clinical Trials, Phase III as Topic; Contraindications; Dabigatran; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Hematoma, Epidural, Spinal; Humans; Morpholines; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Postoperative Nausea and Vomiting; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2013 |
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Brain Ischemia; Clinical Trials, Phase III as Topic; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome | 2015 |
Novel oral anticoagulants in plastic surgery.
Topics: Administration, Oral; Algorithms; Anticoagulants; Dabigatran; Elective Surgical Procedures; Emergencies; Humans; Kidney; Liver; Perioperative Care; Plastic Surgery Procedures; Postoperative Hemorrhage; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles | 2016 |
Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
Topics: Administration, Intravenous; Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Postoperative Hemorrhage; Risk Factors; Treatment Outcome | 2016 |
Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Oral Surgical Procedures; Postoperative Hemorrhage | 2016 |
6 trial(s) available for dabigatran and Blood Loss, Postoperative
| Article | Year |
|---|---|
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; China; Dabigatran; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Heparin; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Time Factors; Treatment Outcome; Warfarin; Whole Blood Coagulation Time | 2021 |
Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain; Catheter Ablation; Dabigatran; Drug Administration Schedule; Female; Humans; Incidence; Intracranial Embolism; Magnetic Resonance Imaging; Male; Middle Aged; Perioperative Period; Postoperative Hemorrhage; Prospective Studies; Treatment Outcome | 2019 |
Comparison of minor bleeding complications using dabigatran or enoxaparin after cemented total hip arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies | 2014 |
Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Case-Control Studies; Dabigatran; Female; Hemoglobins; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; Postoperative Hemorrhage; Prospective Studies; Warfarin | 2014 |
Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thromboembolism | 2016 |
Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Benzimidazoles; Dabigatran; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Pyridines; Risk | 2012 |
35 other study(ies) available for dabigatran and Blood Loss, Postoperative
| Article | Year |
|---|---|
Thromboembolic and bleeding complications following primary total knee arthroplasty : a Danish nationwide cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement, Knee; Dabigatran; Dalteparin; Denmark; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Proportional Hazards Models; Registries; Rivaroxaban; Tinzaparin; Venous Thromboembolism; Young Adult | 2021 |
Anticoagulation and cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Thromboembolism; Warfarin | 2019 |
Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Blood Loss, Surgical; Dabigatran; Eye Hemorrhage; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Israel; Male; Middle Aged; Phacoemulsification; Postoperative Hemorrhage; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism | 2019 |
Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Endoscopic Mucosal Resection; Female; Humans; Japan; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stomach; Stomach Neoplasms; Thiazoles; Thromboembolism; Warfarin | 2021 |
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Carotid Artery Diseases; Cerebral Infarction; Dabigatran; Digestive System Surgical Procedures; Elective Surgical Procedures; Embolism; Endoscopy; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Orthopedic Procedures; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thromboembolism; Urologic Surgical Procedures; Vascular Surgical Procedures | 2020 |
Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Dermatologic Surgical Procedures; Female; Humans; Ischemic Attack, Transient; Male; Perioperative Care; Postoperative Hemorrhage; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban | 2021 |
Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon.
Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Cardiac Catheters; Cerebrovascular Disorders; Cryosurgery; Dabigatran; Drug Administration Schedule; Drug Monitoring; Equipment Design; Factor Xa Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Male; Middle Aged; Phenprocoumon; Postoperative Hemorrhage; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Time Factors; Treatment Outcome; Vitamin K | 2017 |
Bleeding Complications After Use of Novel Oral Anticoagulants in Patients Undergoing Cardiac Surgery.
Topics: Aged; Anticoagulants; Blood Transfusion; Cardiac Surgical Procedures; Critical Care; Dabigatran; Female; Heart Diseases; Humans; Length of Stay; Male; Postoperative Hemorrhage; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Rivaroxaban | 2018 |
Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Blood Coagulation; Blood Loss, Surgical; Clinical Decision-Making; Cost-Benefit Analysis; Dabigatran; Databases, Factual; Drug Costs; Female; Hospital Costs; Humans; Italy; Male; Middle Aged; Patient Selection; Postoperative Hemorrhage; Retrospective Studies; Young Adult | 2018 |
Management of dabigatran-induced bleeding: expert statement.
Topics: Administration, Oral; Antithrombins; Austria; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Humans; Monitoring, Intraoperative; Postoperative Hemorrhage; Practice Guidelines as Topic; Thrombosis | 2013 |
Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Length of Stay; Male; Medical Audit; Middle Aged; Postoperative Care; Postoperative Hemorrhage; Prospective Studies; Venous Thromboembolism | 2014 |
[Rivaroxaban, dabigatran and apixaban: new anticoagulants in operative urology].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Dabigatran; Humans; Morpholines; Postoperative Hemorrhage; Premedication; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Treatment Outcome; Urologic Surgical Procedures | 2014 |
Haemostasis. Part 2: Medications that affect haemostasis.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Fibrinolytic Agents; Hematologic Agents; Hemostasis, Surgical; Heparin; Humans; International Normalized Ratio; Oral Hemorrhage; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Assessment; Warfarin | 2014 |
Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty.
Topics: Aged; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Body Fluids; Dabigatran; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Thromboembolism | 2014 |
Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest.
Topics: Aged; Antithrombins; Aortic Aneurysm, Thoracic; Aortic Dissection; Benzimidazoles; beta-Alanine; Dabigatran; Hemostatic Techniques; Humans; Male; Postoperative Hemorrhage; Vascular Surgical Procedures | 2014 |
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Blood Loss, Surgical; Dabigatran; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Perioperative Care; Postoperative Hemorrhage; Propensity Score; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Warfarin | 2015 |
Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
Topics: Antithrombins; Blood Coagulation Tests; Blood Loss, Surgical; Case-Control Studies; Chromatography, Liquid; Dabigatran; Drug Administration Schedule; Drug Monitoring; Humans; Limit of Detection; Linear Models; Partial Thromboplastin Time; Perioperative Care; Postoperative Hemorrhage; Predictive Value of Tests; Reproducibility of Results; Risk Factors; Tandem Mass Spectrometry; Thrombin Time; Time Factors | 2015 |
The management of dental patients taking new generation oral anticoagulants.
Topics: Anesthetics, Local; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Dental Care for Chronically Ill; Drug Interactions; Factor Xa Inhibitors; Hemostatic Techniques; Humans; Morpholines; Oral Surgical Procedures; Postoperative Hemorrhage; Practice Guidelines as Topic; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Warfarin | 2014 |
Pharmaceuticals: private prescription.
Topics: Antifibrinolytic Agents; Antithrombins; Dabigatran; Formularies, Dental as Topic; Humans; Postoperative Hemorrhage; Tooth Extraction; Tranexamic Acid | 2015 |
Emergency reversal of dabigatran for emergency surgery.
Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Coagulation Factors; Dabigatran; Emergency Medicine; Female; Hernia, Femoral; Humans; International Normalized Ratio; Partial Thromboplastin Time; Postoperative Hemorrhage; Treatment Outcome | 2015 |
Postinterventional use of dabigatran in patients undergoing ablation therapy using an accelerated loading dose scheme - a single center experience.
Topics: Administration, Oral; Antithrombins; Atrial Fibrillation; Catheter Ablation; Chemotherapy, Adjuvant; Dabigatran; Drug Administration Routes; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Retrospective Studies; Thromboembolism; Treatment Outcome | 2015 |
A Case of Fatal Bleeding Following Emergency Surgery on an Ascending Aorta Intramural Hematoma in a Patient Taking Dabigatran.
Topics: Aged, 80 and over; Antithrombins; Aorta; Aortic Diseases; Dabigatran; Emergency Treatment; Fatal Outcome; Female; Hematoma; Humans; Postoperative Hemorrhage | 2016 |
[The use of new oral anticoagulants in surgery].
Topics: Anticoagulants; Blood Coagulation; Blood Loss, Surgical; Comorbidity; Dabigatran; Drug Interactions; Drug Overdose; Drug Substitution; Humans; Perioperative Period; Postoperative Hemorrhage; Risk Adjustment; Surgical Procedures, Operative | 2016 |
Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.
Topics: Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Denmark; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Registries; Stroke; Vitamin K | 2016 |
Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Comorbidity; Dabigatran; Databases, Factual; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Length of Stay; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Patient Readmission; Percutaneous Coronary Intervention; Postoperative Hemorrhage; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stents; Stroke; Thrombosis; Venous Thromboembolism; Warfarin | 2016 |
Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Dabigatran; Humans; Intestinal Obstruction; Male; Postoperative Hemorrhage | 2017 |
Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Disease Management; Drug Interactions; Emergencies; Hemorrhage; Humans; Intracranial Hemorrhages; Middle Aged; Postoperative Hemorrhage; Thrombolytic Therapy | 2017 |
Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Blood Transfusion; Cohort Studies; Dabigatran; Endoscopic Mucosal Resection; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Rivaroxaban; Statistics, Nonparametric; Stomach Neoplasms; Thromboembolism; Treatment Outcome; Warfarin | 2017 |
Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
Topics: Administration, Oral; Aged; Antithrombins; Blood Coagulation; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Female; Half-Life; Humans; Male; Middle Aged; Perioperative Care; Postoperative Hemorrhage; Pyrazoles; Pyridones; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Venous Thromboembolism | 2017 |
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.
Topics: Aged; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Factor VIIa; Humans; Male; Postoperative Hemorrhage; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2012 |
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.
Topics: Atrial Fibrillation; Austria; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Perioperative Care; Postoperative Hemorrhage; Practice Guidelines as Topic; Premedication | 2012 |
Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Biological Availability; Blood Coagulation Tests; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Half-Life; Humans; Morpholines; Narcotics; Oral Hemorrhage; Oral Surgical Procedures; Postoperative Hemorrhage; Rivaroxaban; Thiophenes; Warfarin | 2012 |
Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
Topics: Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Colectomy; Combined Modality Therapy; Dabigatran; Emergencies; Erythrocyte Transfusion; Factor VIIa; Fatal Outcome; Female; Hemostatics; Humans; Kidney Diseases; Male; Plasma; Postoperative Hemorrhage; Recombinant Proteins; Renal Dialysis; Resuscitation; Thrombophilia | 2012 |
[Dabigatran therapy--perioperative management and interpretation of coagulation tests].
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Humans; Monitoring, Intraoperative; Postoperative Hemorrhage; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Development of oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Drug Delivery Systems; Drug Design; Enoxaparin; Factor Xa Inhibitors; Humans; Morpholines; Postoperative Hemorrhage; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2007 |